Scientific principles guiding risk-based cervical cancer screening in resource-limited settings
Human papillomavirus (HPV) causes 660,000 cases and 350,000 deaths globally despite effective vaccination, screening, and treatment options; few are feasible to implement in resource-limited settings where the burden of cervical cancer is high. A single-dose, multivalent HPV vaccination of adolescent females could prevent the majority of cancers, making it the undisputed priority. However, vaccination programs leave a decades-long time lag between prophylaxis of HPV infection and cancer prevention in later adulthood. Screening for and treatment of precancer in mid-adulthood could save additional millions of lives. There are pertinent scientific facts concerning HPV natural history and cervical carcinogenesis so firmly established that they are beyond reasonable dispute. With the realization that scientific certainty demands extraordinary evidence that will always be further refined, a group of cervical cancer prevention specialists with experience in resource-limited settings met intending to posit such a set of fundamental scientific principles.
Authors
- Jerome Leslie Belinson (ORCID: https://orcid.org/0000-0003-1399-1053)
- Teresa Norris (ORCID: https://orcid.org/0000-0003-1823-2830)
- Karen Yeates (ORCID: https://orcid.org/0000-0003-3628-0879)
- Nicole G. Campos (ORCID: https://orcid.org/0000-0002-0840-4339)
- Purnima Madhivanan (ORCID: https://orcid.org/0000-0001-7818-3394)
- RACHEL J. MASCH (ORCID: https://orcid.org/0000-0002-3761-858X)
- Jayashree Kalpathy–Cramer (ORCID: https://orcid.org/0000-0001-8906-9618)
- Didem Egemen (ORCID: https://orcid.org/0000-0001-5617-4585)
- Brian Befano (ORCID: https://orcid.org/0000-0003-3614-210X)
- Federica Inturrisi (ORCID: https://orcid.org/0000-0002-3661-0842)
- Ruchi S. Pathak
- Jennifer Boyd-Morin (ORCID: https://orcid.org/0000-0002-8332-4873)
- MARK H. SCHIFFMAN (ORCID: https://orcid.org/0000-0002-4625-2508)
- Miriam Cremer (ORCID: https://orcid.org/0000-0002-5163-8739)
- Suzanne Belinson
- Ignacio Priéto (ORCID: https://orcid.org/0000-0003-0646-6330)
- Ana Karoline da Costa Ribeiro (ORCID: https://orcid.org/0000-0003-0345-3569)
- Vijayalakshmi Ramshankar (ORCID: https://orcid.org/0000-0003-2464-0806)
- Christopher R. Clark
- Silvia de Sanjosé
- Ruifang Wu
- Kanan Desai
- Ana Cecilia Rodriguez
- Devanshi Somaya
- Lisa Lewis
- Steve QuXInfeng
- Imran Morhason Bello
Institutions
- National Institutes of Health (US)
- Harvard University (US)
- Universidade de Brasília (BR)
- University of Ibadan (NG)
- Universidad Rey Juan Carlos (ES)
- University of Washington (US)
- Queen's University (CA)
- University College Hospital, Ibadan (NG)
- Cancer Institute (WIA) (IN)
- University of Surrey (GB)
- Cleveland Clinic Lerner College of Medicine (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Information Management Services (US)
- Peking University Shenzhen Hospital (CN)
- Hospital Universitário de Brasília (BR)
- National Cancer Institute (US)
- Barcelona Institute for Global Health (ES)
- Public Health Research Institute Of India (IN)
- Médecins Sans Frontières (FR)
- University of Arizona Cancer Center (US)
- University of Colorado Anschutz Medical Campus (US)
- Concordia University (CA)
Publication Details
- Journal
- Infectious Agents and Cancer
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1186/s13027-026-00825-9
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00